BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02651727-completion@plaintrial.com
DTSTAMP:20261027T203415Z
DTSTART;VALUE=DATE:201701
SUMMARY:Ph 1 Study of VS-4718\, a FAK Inhibitor\, in Combination With Nab-p
 aclitaxel and Gemcitabine in Advanced Cancer Subjects — estimated comple
 tion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02651727
URL:https://plaintrial.com/trial/NCT02651727
END:VEVENT
END:VCALENDAR
